Bortezomib, an anticancer medication, prevented a recurrence of progressive familial intrahepatic cholestasis type 2 (PFIC2) after a liver transplant by helping a young girl…
Cholestasis
CHOLESTASIS
NewsProtein’s levels in placenta may be key for diagnosing, treating ICP
Intrahepatic cholestasis of pregnancy (ICP), a liver disorder that can affect a pregnant woman, leads to abnormally high levels of a protein called ERp29…
CHOLESTASIS
NewsAlgorithm for genetic tests helps spot cause of newborn cholestasis
In infants with suspected cholestasis, targeted single-gene testing for those with symptoms that indicate a particular, associated disease and broader gene panel testing for…
CHOLESTASIS
NewsNew study finds PFIC3 marked by increased inflammation in liver
In a wide-ranging analysis of thousands of different proteins from liver samples from transplant patients, a team of scientists in Spain discovered potential links to…
CHOLESTASIS
NewsAlbireo Plans Phase 3 Trial of A4250 to Treat Children with Life-threatening Liver Disease
Children with progressive familial intrahepatic cholestasis will be able to take part in a Phase 3 clinical trial of A4250’s ability to combat the rare genetic…
Boston-based Albireo Pharma hosted an April 13 breakfast presentation in New York that featured an overview of the company’s clinical programs as well as a talk by…
Recent Posts
- I’m learning how to let go of worry and embrace the moment
- Trial of combo therapy for MASH-related cirrhosis to start this year
- AI model based on imaging, blood tests may help diagnose biliary atresia
- New hepatitis D drug brelovitug marks milestones in late-stage trials
- Study finds ethnic disparities in common liver disease treatment